As fees of depression and anxiety have increased dramatically, individuals have sought therapies outside the common program of oral antidepressants and speak therapy. Beginning during the mid-2010s, more and more Physicians started offering ketamine to be a treatment for depression. In 2019, the Food and Drug Administration (FDA) approved esketamin